Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

GLUCOPRO SYRINGE, MODEL GPSY-XXXXXXXX

K-Number: K014114 · 2002-06-26

ApplicantNipro Diabetes Systems, Inc.
Decision Date2002-06-26
Product CodeFMF
Advisory CommitteeHO
DecisionSubstantially Equivalent

Device Summary

GLUCOPRO SYRINGE, MODEL GPSY-XXXXXXXX is the device name listed in this FDA 510(k) record. The listed applicant is Nipro Diabetes Systems, Inc.. It received FDA 510(k) clearance on 2002-06-26 under 510(k) number K014114. The device is classified under product code FMF. It was reviewed by the HO advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the GLUCOPRO SYRINGE, MODEL GPSY-XXXXXXXX?

GLUCOPRO SYRINGE, MODEL GPSY-XXXXXXXX is a medical device that received FDA 510(k) clearance on 2002-06-26. The listed applicant is Nipro Diabetes Systems, Inc.. The 510(k) number is K014114.

When did GLUCOPRO SYRINGE, MODEL GPSY-XXXXXXXX receive FDA 510(k) clearance?

GLUCOPRO SYRINGE, MODEL GPSY-XXXXXXXX received FDA 510(k) clearance on 2002-06-26, under 510(k) number K014114.

Who is the listed applicant for GLUCOPRO SYRINGE, MODEL GPSY-XXXXXXXX?

The FDA 510(k) record lists Nipro Diabetes Systems, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for GLUCOPRO SYRINGE, MODEL GPSY-XXXXXXXX?

The FDA product code for GLUCOPRO SYRINGE, MODEL GPSY-XXXXXXXX is FMF.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Nipro Diabetes Systems, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K071613AMIGO INSULIN PUMPK050312AMIGO INSULIN PUMPK013309GLUCOPRO EVO INFUSION PUMPK011120GLUCOPRO INFUSION SET, MODEL GPISXXXXXXXX SERIES

Related Devices (Code: FMF)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K262581GraftGun Universal Graft Delivery System (GDS®)SurGenTec, LLCK252184SOL-M Luer Lock Syringe with Exchangeable Needle TraySol-Millennium Medical, Inc.K253747Disposable Pen Injector (KXYC-03C02, KXYC-03A03)Jiangsu Enjosim Medical Technology Co., Ltd.K260208Ultra-Fine™ SAFETY Insulin Syringeembecta Medical II, LLCK253110Sol-Glide Safety Needle; Sol-Glide Safety Needle with SyringeSol-Millennium Medical, Inc.K260514Profoject™ Safety Needle; Profoject™ Syringe with Safety Needle; Profoject™ Low Dead Space Syringe with Safety NeedleCMT Health PTE., Ltd.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑